TARGET MEDIATED ENDOCYTOTIC DRUG DELIVERY
The present invention is in the field of Intelligent Drug Delivery. Targeted medicines have been developed thereto, using a Targeted Mediated Drug Delivery-technology. This technology leads drugs selectively and specifically into diseased cells/organs, in contrast to "dumping" drugs into t...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
09.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is in the field of Intelligent Drug Delivery. Targeted medicines have been developed thereto, using a Targeted Mediated Drug Delivery-technology. This technology leads drugs selectively and specifically into diseased cells/organs, in contrast to "dumping" drugs into the body. This technology is found to substantially increase the efficacy of disease treatment and reduce side-effects while much smaller amounts of drug(s) are required. In addition, a novel innovative approach is used that can be applied in the treatment of e.g. cancers, auto-immune diseases, viral diseases, transplantation, and diseases associated with inflammation. |
---|---|
Bibliography: | Application Number: EP20210786122 |